EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association between the total dosage of gonadotropin-releasing hormone antagonist during controlled ovarian stimulation and pregnancy outcomes

Fen Tian, Bin Xu, Yanping Li, Jing Zhao iD

Reproduction and Fertility · 01.10.2026 · 7 (4)

DOI: 10.1530/raf-26-0049 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Reproduction and Fertility, online erschienen am 15.10.2026. Verfasst von Fen Tian und 3 weiteren Autor:innen. Beteiligte Einrichtung: Reproductive Medicine Center, Xiangya Hospital of Central South University , Changsha, China. Hauptthemen laut MEDLINE: Ovulation Induction, Gonadotropin-Releasing Hormone, Pregnancy Outcome, Hormone Antagonists. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Graphical Abstract Abstract At present, the gonadotropin-releasing hormone antagonist (GnRH-ant) protocol is increasingly used in controlled ovarian stimulation (COS). However, some studies have shown that the GnRH-ant protocol impairs pregnancy outcomes after fresh embryo transfer owing to decreased endometrial receptivity caused by GnRH-ant administration. The present study aimed to explore whether the total dosage of GnRH-ant was associated with pregnancy outcomes in infertile women undergoing in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) treatment. This retrospective cohort study used data obtained between 1 November 2019 and 31 October 2024. The study included IVF and ICSI cycles using the GnRH-ant protocol. The primary outcome was the clinical pregnancy rate (CPR) per fresh cycle. The secondary outcomes included the embryo implantation rate (IR) and early miscarriage rate (EMR). A total of 3,764 infertile women were included and divided into four groups according to the quartiles of the total antagonist dose. No significant differences were observed in baseline demographics among the four groups, except for body mass index (BMI), basal FSH levels, and basal luteinizing hormone (LH) levels. Gonadotropin (Gn) dosage and COS duration were significantly different among the groups. The CPR, IR, and EMR were comparable among the four groups. Logistic regression analysis showed that female BMI, infertility factors, endometrial thickness on the day of the trigger, and the number, grade, and quality of transplanted embryos were significantly correlated with the CPR; however, antagonist dosage was not correlated with the CPR. In conclusion, there was no association between the total GnRH-ant dosage in the GnRH-ant protocol and the CPR, IR, or EMR after fresh embryo transfer. GnRH-ant should be added promptly during COS with the GnRH-ant protocol. In addition, the total GnRH-ant dosage does not appear to have detrimental effects on pregnancy outcomes after fresh embryo transfer. Lay summary Gonadotropin-releasing hormone antagonist (GnRH-ant) protocols are widely used for ovarian stimulation in fertility treatments, such as in vitro fertilization. Some research has suggested that GnRH-ant might affect endometrial receptivity. This could reduce the chances of embryo implantation and pregnancy. Our study included 3,764 women undergoing embryo transfer using the GnRH-ant protocol. The women were grouped by the total GnRH-ant dose they received. We compared implantation, pregnancy, and miscarriage rates across the groups. We found that pregnancy outcomes were similar regardless of the total dose used. Also, higher doses did not reduce the chances of pregnancy after embryo transfer. This suggests that doctors can adjust the dose according to each patient’s needs without lowering the chance of success.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovulation InductionGonadotropin-Releasing HormonePregnancy OutcomeHormone AntagonistsInfertility, FemaleHumansFemalePregnancyAdultRetrospective StudiesPregnancy RateEmbryo ImplantationFertilization in VitroEmbryo TransferSperm Injections, Intracytoplasmic

Stichwörter der Autor:innen

GnRH-ant protocolIVFgonadotropin-releasing hormone antagonistpregnancy outcomes

Substanzen

Gonadotropin-Releasing HormoneHormone Antagonists

Autor:innen und Institutionen

  • Reproductive Medicine Center, Xiangya Hospital of Central South University , Changsha, China.
  • Clinical Research Center for Women's Reproductive Health in Hunan Province , Changsha, Hunan, China.

ORCID-Profile: Jing Zhao

Zitieren

APA

Tian, F., Xu, B., Li, Y., & Zhao, J. (2026). Association between the total dosage of gonadotropin-releasing hormone antagonist during controlled ovarian stimulation and pregnancy outcomes. Reproduction and Fertility, 7(4). https://doi.org/10.1530/raf-26-0049

Vancouver

Tian F, Xu B, Li Y, Zhao J. Association between the total dosage of gonadotropin-releasing hormone antagonist during controlled ovarian stimulation and pregnancy outcomes. Reproduction and Fertility. 2026;7(4). doi:10.1530/raf-26-0049

BibTeX
@article{Tian2026,
  author = {Tian, Fen and Xu, Bin and Li, Yanping and Zhao, Jing},
  title = {Association between the total dosage of gonadotropin-releasing hormone antagonist during controlled ovarian stimulation and pregnancy outcomes},
  journal = {Reproduction and Fertility},
  year = {2026},
  volume = {7},
  number = {4},
  doi = {10.1530/raf-26-0049}
}
Kostenlos starten →